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Ubiquitin proteases remove ubiquitin monomers or
polymers to modify the stability or activity of proteins
and thereby serve as key regulators of signal
transduction. Here, we describe the function of the
Drosophila ubiquitin-specific protease 36 (dUSP36)
in negative regulation of the immune deficiency (IMD)
pathway controlled by the IMD protein. Overexpres-
sion of catalytically active dUSP36 ubiquitin protease
suppresses fly immunity against Gram-negative
pathogens. Conversely, silencing dUsp36 provokes
IMD-dependent constitutive activation of IMD-down-
stream Jun kinase and NF-kB signaling pathways
but not of the Toll pathway. This deregulation is lost
in axenic flies, indicating thatdUSP36 prevents consti-
tutive immune signal activation by commensal
bacteria. dUSP36 interacts with IMD and prevents
K63-polyubiquitinated IMD accumulation while
promoting IMD degradation in vivo. Blocking the
proteasome in dUsp36-expressing S2 cells increases
K48-polyubiquitinated IMD and prevents its degrada-
tion. Our findings identify dUSP36 as a repressor
whose IMD deubiquitination activity prevents nonspe-
cific activation of innate immune signaling.
INTRODUCTION
Innate immunity relies on immune sensors, such as pathogen-
recognition receptors (PRRs), and their ability to immediately
activate signals in blood cells and immune organs (Janeway
and Medzhitov, 2002). The transcription factors of the nuclear
factor-kappa B family (NF-kB) regulate the expression of stress
and immune response genes, such as proinflammatory cyto-
kines, antiapoptotic genes, or growth factors (Hoffmann and
Baltimore, 2006). Improper activation of these pathways by envi-
ronmental nonpathogenic microbes or in genetic diseases can
lead to serious pathologies such as inflammation and cancersCell Ho(Karin and Greten, 2005; Pamer, 2007). NF-kB factors act as
a surveillance system that is thus permanently repressed through
their association in the cytoplasm with I-kB inhibitory molecules.
Several pathways stimulate NF-kB, including the Toll-like recep-
tors (TLRs) and the tumor necrosis factor-receptor (TNF-R)
pathways. These receptors signal through scaffolding proteins
that are subjected to ubiquitination. Depending on their nature,
ubiquitin chains can target proteins for degradation or modify
their activated status (Terzic et al., 2007). Notably, conjugation
of K63-linked polyubiquitin (K63-polyUb) chains to the scaf-
folding protein RIP1 is required downstream of the TNF-R for
the activation of TGF-b-activated kinase 1 (TAK1) and I-kB kinase
(IKK) (Ea et al., 2006; Legler et al., 2003). IKK then triggers the
phosphorylation of I-kB and its proteasomal degradation through
the linkage of K48-polyUb chains by the E3 ubiquitin ligase SCF
(Chen et al., 1996), thus releasing free NF-kB for nucleus translo-
cation. A few deubiquitinases (CylD, A20, and Cezanne) have
been described to mediate transient inhibition of ubiquitin-
dependent activation of the NF-kB pathway (Brummelkamp
et al., 2003; Enesa et al., 2008; Kovalenko et al., 2003; Trompouki
et al., 2003; Wertz et al., 2004).
In the fruit flyDrosophilamelanogaster, two conserved immune
signaling pathways, Toll and IMD (immune deficiency), are
strongly induced in fat-body cells upon infection (Ferrandon
et al., 2007; Lemaitre and Hoffmann, 2007). The Toll pathway is
mainly activated by Gram-positive bacteria and fungi and results
in the activation of the NF-kB-like Drosophila immune factor,
which induces a set of antimicrobial peptide genes, including
Drosomycin (Drs) (Lemaitre et al., 1996). The IMD pathway is acti-
vated predominantly by Gram-negative bacteria and results in
the activation of another set of antibacterial peptide genes,
including Diptericin (Dipt) and Attacin (Att) (Georgel et al., 2001;
Lemaitre et al., 1995; Onfelt Tingvall et al., 2001; Vidal et al.,
2001). The IMD pathway is induced by the direct recognition of
peptidoglycan via the receptor PGRP-LC/ird7 that interacts
with the IMD protein (Choe et al., 2002, 2005; Gottar et al.,
2002). IMD is a scaffolding molecule mediating the activation of
TAK1, which then drives the activation of two different down-
stream pathways (Boutros et al., 2002; Georgel et al., 2001; Vidal
et al., 2001). On one hand, transient activation of the Jun kinasest & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc. 309
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Drosophila USP36 Prevents IMD-Dependent SignalsFigure 1. dUsp36 Overexpression Suppresses Fly Immunity
(A) Forty 5-day-old flies were infected with P. aeruginosa, and their survival was followed over 2 days at 20C. daGal4/UY1507 flies (da>UY1507) presented
a sensitive phenotype compared to other UY (#1–4) insertions or to daGal4/+ control flies (p = < 0.001, chi-squared test).
(B) Map of UY1507 insertion in CG5505 transcription unit. Three predicted isoforms (CG5505-RB, -RC, and -RD) are indicated (all isoforms available at http://
flybase.org/reports/FBgn0035633.html). The UY1507 insertion is situated upstream of CG5505-RB and -RC. Grey box corresponds to coding sequence, and
black box indicates USP catalytic domain. Black line indicates the extension of the dUsp36D43 deficiency. Double-strand line indicates location of inverted
repeats used to silence dUsp36 in vivo (P{UAS-Usp36-IR}).
(C) Percentage of sequence identity between CG5505-RC encoded protein (dUSP36) and hUSP36 predicted protein. In addition to the USP domain (black box,
37% identity), the two sequences align over two other conserved domains (boxes 1 and 2, showing 42% and 40% identity, respectively).310 Cell Host & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc.
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Drosophila USP36 Prevents IMD-Dependent Signals(JNK) pathway induces genes encoding proteins required for
wound repair and the downregulatory phosphatase puckered
(puc). On the other hand, TAK1 phosphorylates Kenny (KEY),
the Drosophila IKKg, which then phosphorylates the NF-kB-like
factor Relish (Rel) (Kleino et al., 2005; Silverman et al., 2000). As
in mammalian cells, a set of conserved ubiquitin ligases regulates
the Drosophila Toll and IMD pathways (Chiu et al., 2005; Khush
et al., 2002; Tsuda et al., 2005; Zhou et al., 2005). The orthologous
Drosophila CylD is the sole deubiquitinase whose function has
been assessed in Drosophila immune response: it specifically
binds KEY, and its overexpression downregulates antimicrobial
peptide gene expression (Tsichritzis et al., 2007). At the present
date, however, deubiquitinases that would act on upstream
elements of the IMD pathway still remain to be identified.
In this study, we describe the function of Drosophila ubiquitin-
specific protease 36 (dUSP6) in the inhibition of immune
signaling. Independent studies showed that dUSP36 (Scrawny
[Scny]) is required for stem cell maintenance and histone H2B
deubiquitination (Buszczak et al., 2009) and is also involved in
apoptosis regulation during development (Emperor’s thumb
[ET]) (Ribaya et al., 2009). Since we show that dUsp36/scny/et
is homologous to human USP36 (hUSP36) (Kim et al., 2004,
2005; Quesada et al., 2004), we use the nomenclature dUsp36
to indicate its inclusion in the USP gene family (Nijman et al.,
2005). We demonstrate that dUSP36 is required to prevent IMD
activation both in Drosophila S2 cells and in adult flies. Overex-
pression of dUSP36 suppresses Drosophila immunity and
antimicrobial peptide gene expression via its catalytic activity.
Moreover, we created a nulldUsp36allele (dUsp36D43), and using
conditional rescue during development or conditional expression
of a silencing transgene in adult gut and fat-body cells, we
observed that loss of dUsp36 expression induces constitutive
deregulation of the IMD and JNK pathways but not of the Toll
pathway. IMD activation in dUsp36-silenced gut was lost in
axenic flies or in IMD-silenced flies, indicating that dUSP36
prevents IMD activation by environmental bacteria and is acting
upstream of IMD. Indeed, dUSP36 interacts with IMD in vivo,
and its expression, but not that of the catalytically dead mutant,
decreased the amount of both endogenous IMD and K63-ubiqui-
tinated forms. Similar results were obtained in S2 cells where, in
addition, blocking the proteasome in dUsp36-overexpressing
cells increased K48-ubiquitinated IMD and prevented its degra-
dation. Therefore, dUSP36 likely prevents signal transduction
by removing K63-polyUb and indirectly promoting the linkage
of K48-polyUb.
RESULTS
A P{UAS} Insertion in dUsp36 Suppresses Fly Immunity
to Gram-Negative Pathogens
In a gene candidate approach for genes involved in the
Drosophila immune response (Monnier et al., 2002) (see
Experimental Procedures), we selected the insertion P{Mae-
UAS.6.11}UY1507, which caused sensitivity to the Gram-Cell Honegative virulent strain Pseudomonas aeruginosa (Figure 1A).
UY1507 is inserted in the CG5505 gene 50 to -RB and -RC
isoforms (Figure 1B). It drives the expression of twoCG5505 tran-
scripts, which likely correspond to these two isoforms and further
provoked a marked reduction ofDipt induction following bacterial
infection (Figure S1A). Quantification ofCG5505mRNAs showed
an 8-fold increase in daGal4/UY1507 flies (Figure S1B). Blast
analysis revealed two close homologous proteins in the human
genome: hUSP36 and hUSP42. The longest isoform, CG5505-
RD (Figure 1B), encodes a predicted protein possessing the
highest homology with hUSP36. Indeed, in addition to the USP
catalytic domain (black box), two other conserved domains
presenting 40% and 42% identity with hUSP36 were detected
in the N-terminal and C-terminal parts (Figure 1C, boxes 1 and
2). These domains are not present in hUSP42 and do not share
any similarities with previously identified domains. We thus
conclude that hUSP36 is the closest homolog to CG5505.
To assess whether the immune phenotype observed with
the insertion would be due to dUsp36 overexpression, we
constructed P{UAS-dUsp36} transgenic flies expressing the
CG5505-RB transcript. Transgene expression was induced
through the heat shock (HS) driver line, HSGal4, and resulted
in high levels of dUsp36 transcripts (see below). Overexpressing
dUsp36 decreased the induction of both the IMD target gene
Dipt at 45 min, 6 hr, and 9 hr postinfection (Figure 1D) and the
JNK target gene puc at 45 min postinfection (Figure 1E). More-
over, as observed with the UY1507 insertion, overexpressing
dUsp36 provoked fly sensitivity to P. aeruginosa and E. cloacae
but not to nonpathogenic bacteria Agrobacterium tumefaciens
(Figures S1C–S1E) or Escherichia coli (not shown). Overexpress-
ing dUsp36 thus prevents the activation of the IMD pathway and
causes flies’ sensitivity to Gram-negative pathogens.
dUSP36 Suppresses Fly Immunity via
Its Catalytic Activity
Several intermediates of the IMD pathway might be activated
through the linkage of ubiquitin monomers or polymers. This rai-
ses the possibility that dUSP36 is a deubiquitinating enzyme
regulating the IMD pathway through its catalytic activity. We
showed that the catalytic domain of dUSP36, like its human
counterpart hUSP36 (Kim et al., 2004; Quesada et al., 2004),
hydrolyzed a Ub-b-gal substrate when coexpressed in bacteria
(Figure S2A) and that both human and Drosophila proteins also
digested polyUb isopeptide bound in vitro (Figures S2B and
S2C). Mutating the two catalytic conserved residues (C*H*) re-
sulted in a total loss of activity (Figures S2A and S2B). To test
for the requirement of dUSP36 catalytic activity in the negative
regulation of the IMD pathway in vivo, we constructed P{UAS-
dUsp36C*H*}-transgenic flies expressing the catalytically dead
mutant. HS-driven expression of UAS-dUsp36C*H* induced
amounts of transcript and protein similar to the wild-type
form (Figures S3A and S3B). Unlike dUSP36, overexpressing
dUSP36C*H* did not inhibit Dipt induction following E. coli infec-
tion (Figure 2A). Similarly, overexpressing dUSP36, but not the(D and E) Quantitative analysis of Dipt (D) and puc (E) mRNAs by quantitative RT-PCR in noninfected (NI) flies or at 45 min (450), 6 hr, or 9 hr postinfection with
E. coli. Results are expressed as percent of the maximal induction level observed in dUSP36-expressing flies (HS>dUSP36) compared to control HS/+ flies
(100%). Values represent the mean of three technical replicates. Error bars represent SD. One representative experiment out of three biological independent
experiments is presented. Significant difference of p < 0.05 (*) or of p < 0.01 (**) compared to HS/+ control flies (Student’s t test).st & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc. 311
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Drosophila USP36 Prevents IMD-Dependent SignalsFigure 2. dUSP36 Suppresses Fly Immunity through Its Catalytic Activity
(A) Analysis of Dipt mRNAs by quantitative RT-PCR in noninfected (NI) flies or at 6 hr postinfection with E. coli. Results are expressed as the fold induction level
compared to noninfected HS/+ flies (NI). HS-driven expression of dUsp36 (in UAS-dUsp36/Y;HSGal4/+ flies) strongly reduces Dipt induction following infection
(HS>dUSP36). In contrast, HS-driven expression of the mutant dUsp36C*H* has no effect on Dipt expression level, as observed in two independent transgenic
lines (HS>dUSP36C*H* #3 and #5).
(B and C) Similar analysis ofDiptmRNAs at 3, 6, and 9 hr postinfection with eitherP. aeruginosa (B) or E. cloacae (C) showed that overexpressing dUSP36, but not
dUSP36C*H*, impaired Dipt induction. Values in (A)–(C) represent the mean of three technical replicates. Error bars represent SD. One representative experiment
out of three biological independent experiments is presented. Significant differences of p < 0.01 (**) or p < 0.05 (*).
(D and E) Forty 5-day-old flies were infected with P. aeruginosa (D) or E. cloacae (E) 16 hr following HS treatment, and their survival kinetics were followed over
2 days. The key mutant is used as a Gram-negative sensitive control. HS-driven expression of the dUsp36 transgene (HS>dUSP36), but not of dUsp36C*H*
(HS>dUSP36C*H*), results in fly sensitivity to both pathogens as compared to HSGal4/+ control flies (p < 0.01, chi-squared test).312 Cell Host & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc.
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Drosophila USP36 Prevents IMD-Dependent SignalsFigure 3. dUSP36 Is Required to Prevent
Constitutive Induction of the IMD Pathway
In Vivo
(A) Analysis of Dipt, AttA, puc, and Drs mRNAs by
quantitative RT-PCR. Control flies issued from perfect
excision of UY1507 (Control) or UAS-dUsp36/+;
Gal80ts/+; daGal4,dUsp36D43/dUsp36D43 flies
(dUsp36D43cond) were raised at 30C during develop-
ment, and then a set of flies was placed 4 days at
18C at the adult stage—preventing UAS-dUsp36
expression—and was compared to control siblings
maintained at 30C. Temperature change has no
effect on Dipt expression in control flies placed at
either 18C or 30C. Significant difference between
dUsp36D43cond flies raised at 30C compared to
18C was p < 0.05 (*) (Student’s t test).
(B) Fat-body-directed silencing of dUsp36 was in-
duced at the adult stage by raising c564Gal4/Gal80ts,
UAS-dUsp36-IR flies at 18C during development
and rearing adults for 4 days at 30C (siUsp36, hatched
bars). Results are presented as the fold induction of
each antimicrobial peptide-encoding gene mRNA
(Dipt, AttA, or Drs) or the phosphatase-encoding
gene puc in dUsp36 fat-body-silenced flies compared
to control flies (black bars). Significant difference with
control flies was p < 0.01 (**).
(C-F) Gut-directed silencing of dUsp36 was induced
with the NP1Gal4 driver line using protocol similar to
that in (B). Ectopic activation of a Dipt-lacZ reporter
transgene is observed only in the anterior midgut (C,
arrows on the larger view shown on the top right of
each picture). Area of endogenous b-gal is indicated
(end b-gal). Induction of Dipt, AttA and puc, or
dUsp36 (D–F) was monitored by quantitative RT-
PCR on isolated adult guts. Guts from flies raised in
normal conditions are shown in (D) and guts isolated
from axenic flies or from their control siblings raised
in similar conditions in (E) and (F). Values in (A), (B),
and (D)–(F) represent the mean of three technical repli-
cates. Error bars represent SD. One representative
experiment out of three biological independent exper-
iments is presented. Significant difference with
control flies of p < 0.01 (**) or p < 0.05 (*).catalytically inactive form, inhibited the induction of Dipt
following infection by the pathogenic bacteria P. aeruginosa
and E. cloacae (Figures 2B and 2C). Decreased antimicrobial
peptide expression is associated with increased fly sensitivity to
these Gram-negative pathogens when overexpressing dUSP36,
but not the catalytically inactive form (Figures 2D and 2E). Our
experiments demonstrate that dUSP36 negatively regulates
the IMD pathway in vivo and suppresses fly immunity through
its catalytic activity. Thus, we conclude that the deubiquitinating
activity of dUSP36 is essential for inhibition of the IMD pathway.
dUSP36 Prevents Constitutive Activation of IMD
and JNK Pathways
To decipher the in vivo function of dUSP36, we created the null
mutation dUsp36D43 (Figure 1A). dUsp36D43 homozygotes were
lethal at early larval stage (E.T., unpublished data). Lethality of
dUsp36D43 mutants was rescued by expressing the UAS-
dUsp36 construct under the control of the ubiquitous daGal4
driver, allowing for the recovery of viable adult flies. This indicatesCell Hothat loss of dUsp36 is responsible for lethality of dUsp36D43
homozygotes. To elucidate the requirement of dUSP36 in the
immune response at the adult stage, the lethality of dUsp36D43
mutants was rescued by expressing the UAS-dUsp36 transgene
during development under the control of the daGal4 driver, itself
conditionally inactivated at the adult stage by the Gal80 thermo-
sensitive (Gal80ts) inhibitor of Gal4 (dUsp36D43cond) (McGuire
et al., 2003). A 20-fold increase of Dipt expression was observed
in dUsp36D43cond flies placed 4 days at 18C compared to flies of
the same genotype maintained at 30C (Figure 3A). This increase
was not observed in control flies raised at 18C or 30C
(Figure 3A). Loss of dUsp36 expression at the adult stage thus
results in a constitutive activation of the IMD pathway.
We then constructed P{UAS-dUsp36-IR}-transgenic lines
expressing inverted repeat cDNA sequences to inactivate
dUsp36 expression in vivo (Figure 1A). Ubiquitous expression
of this construct resulted in early larval lethality, thus suggesting
that it efficiently silenced dUsp36, as confirmed by monitoring
dUSP36 protein level from total fly extracts (Figure S3C).st & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc. 313
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Drosophila USP36 Prevents IMD-Dependent SignalsFigure 4. dUSP36 Function Depends on IMD In Vivo
(A–C) Analysis of Dipt mRNAs by quantitative RT-PCR. Dipt expression was
analyzed in flies overexpressing IMD alone (HS>IMD) or in combination with
dUSP36 (HS>IMD;dUSP36) at 16 hr following HS treatment (A). Flies were
submitted to a mild HS for 1 hr at 37C, and Dipt expression was analyzed
at 4 and 8 hr following HS (B). Dipt expression was induced by overexpressing
PGRP-LC alone (HS>PGRP-LC) or with dUSP36 (HS>dUSP36;PGRP-LC).
Conditional silencing in adult fat body of dUsp36 (c564>dUsp36-IR) (genotype:
c564Gal4/Gal80ts,UAS-dUsp36-IR flies) or of dUsp36 and Imd jointly
(c564>dUsp36-IR,Imd-IR) (genotype: c564gal4/Gal80ts,UAS-dUsp36-IR;314 Cell Host & Microbe 6, 309–320, October 22, 2009 ª2009 ElsevdUsp36 silencing in fat-body cells using the c564Gal4 driver line
(Hrdlicka et al., 2002) also resulted in larval lethality, indicating
that dUSP36 function in the fat body is vital during development.
Expression of the UAS-dUsp36-IR transgene was then condi-
tionally controlled with the Gal80ts inhibitor 48 hr after pupal eclo-
sion by raising adults for 4 days at 30C. Silencing dUsp36 in the
adult fat body of noninfected flies resulted in Dipt, AttA, and puc
induction (Figure 3B). The relatively low induction level of puc
mRNA (3.7-fold) is significant compared to the 4- to 5-fold induc-
tion observed in infected flies at 45 min postinfection with E. coli
(Figure 1E). In contrast, the low level of induction (2-fold)
observed in the case of Drs is not significant compared to the
40-fold induction observed in M. luteus-infected flies at 48 hr
postinfection (data not shown) (Figure 3B). These results indicate
that IMD and JNK pathways are specifically activated in dUsp36-
silenced fat-body cells.
In addition to fat-body cells, the gut is another immune-
competent tissue that can activate the IMD pathway upon oral
infection (Buchon et al., 2009). dUsp36 conditional silencing
with the gut-specific driver line NP1Gal4 carrying the dipt-lacZ
reporter gene resulted in ectopic activity of b-galactosidase in
the anterior midgut (Figure 3C). Deregulation of Dipt, AttA, and
puc was further quantified from dUsp36-silenced guts and
reached, respectively, 5-, 8-, and 2-fold induction compared to
control guts (Figure 3D). The presence of environmental bacteria
may be responsible for IMD pathway constitutive activation in
dUsp36-silenced gut. Axenic flies without commensal bacteria
were created by sterilizing eggs and raising flies in sterile condi-
tions. Interestingly, no deregulation of Dipt and AttA was
observed in dUsp36-silenced axenic fly guts compared to
nonsterilized siblings raised in similar conditions (Figure 3E).
More than 2-fold decreased expression of dUsp36 was moni-
tored in corresponding guts (Figure 3F). dUSP36 is thus required
to permanently prevent activation of IMD-dependent pathway in
response to environmental bacteria.
dUSP36 In Vivo Function Depends on IMD
Overexpressing upstream components of the IMD pathway such
as PGRP-LC, IMD, or TAK1 results in antimicrobial peptide gene
induction in the absence of immune challenge (Choe et al., 2002;
Georgel et al., 2001; Vidal et al., 2001). To assess at which level
dUSP36 acts on the IMD pathway, dUSP36 was coexpressed
with PGRP-LC, IMD, or TAK1 in double-transgenic lines, and
the activation of Dipt was analyzed by quantitative RT-PCR.
HS-driven expression of dUSP36 with IMD decreased the level
of Dipt activation observed with IMD alone (Figure 4A). Because
of the very poor viability of PGRP-LC- and TAK1- overexpressing
flies, we used a milder heat-shock protocol (1 hr at 37C). In
these conditions, overexpressing dUSP36 reduced the level of
UAS-Imd-IR/+) in noninfected flies (NI) is shown in (C). To achieve conditional
silencing, flies were raised at 18C during development and 30C for 4 days
before analysis of Dipt transcripts. Results are expressed as the fold induction
level compared to c564Gal4/+ flies raised in similar conditions. The constitu-
tive deregulation of Dipt gene expression caused by silencing dUsp36 in
c564>dUsp36-IR is totally prevented by cosilencing Imd (c564>dUsp36-
IR,Imd-IR). Values represent the mean of three technical replicates. Error
bars represent SD. One representative experiment out of three biological
independent experiments is presented. Significant differences with control
are indicated: p < 0.05 and p < 0.01 (**) (Student’s t test).ier Inc.
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ure 4B), but not that induced by overexpressing TAK1 (Figure S4),
suggesting that dUSP36 is acting upstream or at the level of IMD.
To further test whether deregulation of the IMD pathway in
dUsp36-silenced fat-body cells depends on the presence of
IMD, both genes were simultaneously silenced at the adult stage
in fat-body cells. We first verified that the UAS-Imd-IR transgene
used in our study efficiently silenced Imd. Indeed, compared to
control flies, silencing Imd in fat-body cells prevented Dipt
expression following E. coli infection and provoked a marked
reduction of detectable endogenous IMD protein (Figure S5).
We then conditionally silenced dUsp36, either alone or in
combination with Imd, in the adult fat body using the Gal80ts
system described above. As previously mentioned, silencing
dUsp36 in the adult fat body resulted in a constitutive
deregulation of the IMD pathway, whereas no deregulation
of Dipt gene expression occurred in double dUsp36- and Imd-
silenced flies (Figure 4C). This last result indicates that deregula-
tion of the IMD pathway mediated by silencing dUsp36 strictly
requires IMD. Importantly, the lethality of dUsp36 null mutants
is not rescued by mutations in the TAK1, Dredd, Diap2, key, or
Imd genes. This indicates that constitutive induction of the
IMD pathway is not the cause for the lethality of dUsp36 null
mutants.
dUSP36 Interacts with IMD
The analysis of the in vivo function of dUSP36 suggests that it
permanently prevents signal transduction through IMD (Choe
et al., 2005). We thus used a coimmunoprecipitation (coIP) assay
in transfected S2 cells to investigate the ability of dUSP36 to
interact with IMD or PGRP-LC (or KEY as a negative control).
Remarkably, IMD, but not PGRP-LC nor KEY, coimmunoprecipi-
tated dUSP36 (Figure 5A). CoIP was further observed in both
directions between dUSP36 and the full-length IMD and
between dUSP36 and IMD N-terminal part (Figure 5B), but not
with IMD C-terminal part (data not shown). To further map the
interaction domain of dUSP36 with IMD, we performed a GST
pull-down assay with two truncated forms of the dUSP36
protein. In this assay, the C-terminal part but not the N-terminal
part of dUSP36 did specifically retain the recombinant IMD
protein (Figure 5C). Finally, the interaction between dUSP36
and IMD was confirmed in vivo with proteins coimmunoprecipi-
tated from fly extracts (Figure 5D).
In a previous study, dUSP36/Scny expression was detected
mainly in the nucleus, where it deubiquitinates H2B (Buszczak
et al., 2009). Since our results indicate that dUSP36 acts at the
level of IMD, which is thought to act in the cytoplasm, we sug-
gested that different isoforms of dUSP36/Scny would display
different subcellular localization. To assess this hypothesis,
the Myc-tagged CG5505-RB isoform used in this study was
expressed in S2 cells together with IMD-V5. Corresponding
proteins were detected in the cell cytoplasm (Figure S6).
dUSP36Decreases IMD andK63-PolyUb IMD Levels and
Promotes IMD Proteasomal-Dependent Degradation
In mammalian cells, K63-linked polyubiquitin chains on RIP1 are
recognized by the ubiquitin-binding domain of TAB2, which
recruits TAK1 (Ea et al., 2006; Legler et al., 2003; Newton
et al., 2008). The deubiquitinase A20 downregulates the signalCell Hosby hydrolyzing K63-linked chains and catalyzing the linkage of
K48-linked chains, thus promoting RIP1 degradation. In
Drosophila, IMD has scaffolding function similar to RIP1. We
observed that IMD is constitutively ubiquitinated by K63-polyUb
chains in vivo (Figure 6A) or when overexpressed in Drosophila
S2-transfected cells (Figure 6B). Expressing dUSP36 but not
the catalytically mutant form dramatically decreased K63-ubiq-
uitinated IMD and also lowered the amount of endogenous full-
length IMD (Figure 6A). Similar results were obtained in S2 cells:
coexpressing dUSP36 with IMD reduced the amount of K63-
ubiquitinated forms of IMD when compared to control cells or
to cells expressing the catalytically inactive mutant dUSP36C*H*
(Figure 6B). In addition, expressing dUSP36 also decreased the
total amount of IMD detected in the cell lysate, thus indicating
that dUSP36 promotes IMD degradation (Figure 6B). Blocking
the proteasome by treating cells with MG132 restored a normal
amount of IMD protein in dUSP36-transfected cells (Figure 6B).
Moreover, K48-ubiquitinated IMD was detected in MG132-
treated cells, and dUSP36 expression in these cells increased
the amount of K48-ubiquitinated forms of IMD (Figure 6B). All
together, these results suggest that dUSP36 hydrolyzes the acti-
vating K63-polyUb chains on IMD. Removal of K63-polyUb
chains may then favor K48-polyUb linkage and subsequent
degradation of IMD.
DISCUSSION
Our work identifies dUSP36 as a deubiquitinating enzyme that
negatively regulates the IMD-dependent signaling pathway in
Drosophila. We show that dUSP36 is required to prevent consti-
tutive activation of the IMD pathway in the absence of immune
challenge. Indeed, silencing dUsp36 either in the whole
organism or only in the adult fat body or gut induces a constitutive
expression of IMD-dependent antimicrobial peptide-encoding
genes. We further showed that deregulation of the pathway
depends on the presence of environmental bacteria, as no
deregulation was observed in guts isolated from axenic flies.
This indicates that dUSP36 is needed to prevent IMD pathway
activation by environmental bacteria and is required for immune
tolerance, as previously shown for PIMS, another negative regu-
lator of the IMD pathway (Lhocine et al., 2008). Deregulation of
the pathway observed in dUsp36-silenced fat body may similarly
occur via bacterial peptidoglycan release crossing the intestinal
barrier. The JNK pathway is also deregulated by dUsp36
silencing, as shown by elevated expression of the JNK target
gene puc. Deregulation of the JNK pathway might be a conse-
quence of IMD activation, since JNK can be activated through
TAK1, itself activated by IMD (Vidal et al., 2001). In contrast,
the expression of Drs, a target gene of the Toll pathway, was
not significantly modified. These results indicate that dUSP36
requirement in the negative regulation of innate immune signals
is specific for the IMD pathway.
Since dUsp36 silencing results in constitutive activation of the
IMD pathway, it could have been expected that dUsp36 mutant
flies would resist better to bacterial infections. In fact, we
observed the opposite phenotype: dUsp36-silenced flies are
more sensitive to infections (data not shown). Deregulation of
immune signals has been previously shown to be detrimental
and to induce fly sensitivity to microbial infections (Bischofft & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc. 315
Cell Host & Microbe
Drosophila USP36 Prevents IMD-Dependent Signalset al., 2006; Gordon et al., 2008; Maillet et al., 2008). Moreover,
independent studies showed pleiotropic functions of dUSP36
that might interfere with fly survival upon infection (Buszczak
et al., 2009; Ribaya et al., 2009). Since a few deubiquitinases
exist in eukaryotic genomes (around 25 in Drosophila mela-
nogaster), it is expected that each enzyme would have several
substrates. Specific interactions with other proteins would deter-
mine substrate specificity. It is also important to note that, even if
hydrolyzing both K48- and K63-linked ubiquitin chains in vitro,
a deubiquitinating enzyme may specifically remove K63-linked
Figure 5. dUSP36 Interacts with IMD
(A)DrosophilaS2 cells were cotransfected with the
expression constructs encoding for PGRP-LC-V5,
IMD-V5, or KEY-V5 and dUSP36-Myc. Cell
extracts were coimmunoprecipitated with anti-V5
antibodies and analyzed by western blot with
anti-Myc and anti-V5 antibodies (IPV5, aV5: not
shown). Presence of recombinant proteins in the
input was assessed by western blot of cell extracts
with anti-V5 and anti-Myc antibodies. The IMD
protein migrates as four major bands ranging in
size from 20 to 35 kDa. The two higher bands,
which correspond, respectively, to the full-length
(35 kDa) and a cleaved form at 30 kDa (N. Silver-
man, personal communication), are shown.
(B) Similar experiments were performed in cells
expressing dUSP36-Myc with either IMD-V5 or
its N-terminal part (IMDNter-V5). Cell extracts
were immunoprecipitated with either anti-V5 anti-
bodies (IPV5, WBaMyc) or anti-Myc antibodies
(IPaMyc, WBaV5).
(C) S2 cells were transfected with the expression
construct encoding IMD-V5 and lysed after 48 hr.
Cells lysates were subjected to either immunopre-
cipitation with an antibody against V5 or to GST
pull-down assays using GST fusion proteins with
either the dUSP36[41–457] N-terminal part
(dUSP36 Nter) or the dUSP36[418–968] C-ter-
minal part (dUSP36 Cter) or with GST alone (GST).
Lysates were colored with Ponceau red to visu-
alize GST fusion proteins in the input (bottom part).
(D) Protein extracts were prepared from flies over-
expressing IMD alone (HS>IMD) or with dUSP36
(HS>IMD; dUSP36) at 16 hr following HS. IMD
was immunoprecipitated from fly extracts with
antibodies directed against IMD (gift from J.M.
Reichhart) and analyzed with anti-Scny (dUSP36)
(Buszczak et al., 2009). Anti-Scny antibodies
revealed a unique band at the expected size
(130 kDa) showing that dUSP36 and IMD form a
complex in vivo. Fly extracts were revealed with
anti-IMD and anti-Scny to show presence of corre-
sponding proteins in the fly extracts (*, unspecific
band).
chains on a given substrate in vivo. This
seems to be the case for dUSP36 (this
study) and has previously been observed
with A20 (Wertz et al., 2004).
OverexpressingdUSP36butnotacata-
lytically inactive form inhibits the activa-
tion of the IMD pathway, resulting in
increased fly sensitivity to Gram-negative
pathogens. This indicates that dUSP36 negatively regulates the
IMD pathway through its catalytic activity. We further provide
evidence that dUSP36 acts on the IMD pathway at the level of
IMD. First, overexpressing dUSP36 reduces the constitutive acti-
vation of the pathway provoked by overexpressing either PGRP-
LC or IMD, but not that produced by overexpressing TAK1.
Second, constitutive activation of the IMD pathway induced by
dUSP36 silencing strictly depends on the presence of IMD.
Finally, dUSP36 associates with the N-terminal part of IMD
through its C-terminal domain, and its expression, but not the316 Cell Host & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc.
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Drosophila USP36 Prevents IMD-Dependent SignalsFigure 6. dUSP36 Decreases K63-Ubiquitinated IMD while Promoting Its Proteasomal-Dependent Degradation
(A) Protein extracts were prepared from control flies (HS/+) or flies expressing either dUSP36 (HS>USP36) or the catalytically dead form (HS>USP36C*H*) at 16 hr
following HS. IMD was immunoprecipitated from fly extracts and analyzed with anti-K63 antibodies (Newton et al., 2008) (IPV5 aK63) or anti-Imd (IPV5 aV5). Fly
extracts were revealed with anti-IMD (Lysates aIMD) and anti-Scny (Lysates aScny) to detect the corresponding proteins in the input (*, unspecific band). IPV5
aK63 revealed bands ranging from 31 to 50 kDa showing several K63-ubiquitinated IMD species.
(B) Drosophila S2 cells were transfected with IMD-V5 alone or with either wild-type dUSP36-Myc or mutated dUSP36C*H*-Myc. Cell extracts were immunopre-
cipitated with anti-V5 antibodies and analyzed with anti-K63 antibodies to reveal K63-ubiquitinated forms of IMD. Cell lysates were analyzed with aV5, aMyc, or
aTub to reveal the amount of, respectively, IMD-V5, dUSP36-Myc, and Tubulin, which serves as an internal loading control. Expressing dUSP36 but not
dUSP36C*H* reduced the amount of K63-ubiquitinated IMD and the total amount of nonubiquitinated IMD. In a second set of samples (right panels), proteasomal
degradation of proteins was blocked by MG132. Cell extracts were similarly immunoprecipitated with anti-V5 antibodies and analyzed with anti-K48 antibodies,
revealing K48-ubiquitinated forms of IMD at sizes similar to K63-ubiquitinated forms. The total amount of IMD stays unchanged in dUSP36-expressing cells
treated with MG132.expression of the catalytically dead mutant, decreased the
amount of K63-ubiquitinated IMD and of full-length IMD both
in vivo and in S2 cells. Since treating S2 cells with a proteasome
inhibitor restored a normal amount of IMD and enhanced the
amount of K48-ubiquitinated forms of IMD, it is likely that IMD,
like the human scaffolding protein RIP1, is subjected to both
K48- and K63-linked ubiquitination and that dUSP36 indirectly
promotes K48-linked polyubiquitination and degradation of
IMD by hydrolyzing K63-polyubiquitin chains (Figure 7). The
fact that dUsp36 loss of function provokes a constitutive deregu-
lation of the IMD pathway argues in favor of the existence of
a steady state of the IMD pathway that is maintained at a very
low basal level through the ubiquitination/deubiquitination
reversible chemical modification, despite the presence of envi-
ronmental microbes (Figure 7). Interestingly, IMD is K63-ubiquiti-
nated in vivo upon infection by the DIAP2 ubiquitin ligaseCell Hos(N. Silverman, personal communication), reinforcing a model
where IMD activation depends on its ubiquitinated status.
In a scheme where dUSP36 would be required to buffer the
pathway by preventing constitutive K63-linked ubiquitination of
IMD, it remains to be determined how the activity of dUSP36 is
itself regulated. Whereas a constant basal level of dUSP36 might
insure a permanent negative regulation of the pathway, a specific
signal might block dUSP36 activity during infection. As
described for the human USP36 protein (Kim et al., 2005), the
dUSP36 sequence presents PEST domains (data not shown),
which are characteristic for unstable proteins and might drive
transient dUSP36 degradation upon infection. The hypothesis
that dUSP36 inhibition might be achieved at the protein level is
supported by the fact that we did not detect major transcriptional
changes of dUsp36 transcript upon infection (data not shown). In
contrast, several data indicate that the mouse homolog DUB-1t & Microbe 6, 309–320, October 22, 2009 ª2009 Elsevier Inc. 317
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Dependent Regulation of IMD
Linkage of K63-polyUb chains on IMD would
promote signaling to TAK1, whereas linkage of
K48-linked polyubiquitin chains on IMD would
promote its degradation. The IMD pathway would
be permanently activated by environmental
bacteria and inhibited by dUSP36 via the hydro-
lysis of K63-polyUb chains linked to IMD. This
removal would favor K48 polyubiquitination of
IMD, then promoting its proteasomal-dependent
degradation.gene expression is upregulated by inflammatory cytokines (Baek
et al., 2004; Zhu et al., 1996).
The IMD pathway is negatively regulated at many levels,
showing the importance of preventing its constitutive activation
for fly fitness. The amidase activity of some secreted PGRPs
digest activating peptidoglycan (Bischoff et al., 2006; Zaidman-
Re´my et al., 2006), PGRP-LF prevents PGRP-LC activation at
the cell membrane (Maillet et al., 2008; Persson et al., 2007),
and negative feedback loops or specific negative regulators act
at the intracellular level, including the ubiquitin ligase POSH
inducing TAK1 ubiquitination and degradation (Gordon et al.,
2008; Tsuda et al., 2005). Three independent studies of the
negative regulator PIRK pointed out that negative regulation of
the IMD pathway at the level of the complex formed by PGRP-
LC and IMD is a crucial step in the negative control of signal trans-
duction (Aggarwal et al., 2008; Kleino et al., 2008; Lhocine et al.,
2008). However, despite the identification of ubiquitin ligases
promoting IMD activation (Zhou et al., 2005), evidence for IMD
ubiquitination was lacking, and ubiquitin proteases acting on
upstream elements of the IMD pathway still remained to be iden-
tified (Tsichritzis et al., 2007). Our study demonstrates that IMD is
ubiquitinated by either K63-linked or K48-linked polyubiquitin
chains. Furthermore, it identifies dUSP36 as a deubiquitinating
enzyme involved in the negative control of innate immune
signaling via IMD deubiquitination.
EXPERIMENTAL PROCEDURES
Fly Strains, Screening, and Infections
Flies were raised on standard culture medium at 25C except if otherwise indi-
cated. We screened a subset of 120 P{Mae-UAS.6.11}UY insertions selected
for their modified stress response (Monnier et al., 2002). UY lines were crossed
with the daGal4 driver line, and the progeny were infected by septic injury with
a diluted exponential-phase culture of P. aeruginosa (Fauvarque et al., 2002) to
select more resistant or sensitive lines. A second readout assay was con-
ducted by analyzingDipt expression upon infection by Gram-negative bacteria
E. coli, A. tumefaciens, or E. cloacae.
Mapping the UY1507 insertion was performed by genomic PCR. Jumpout of
the UY1507 element was conducted following standard procedure (Robertson
et al., 1988). One lethal deletion was recovered among 160 independent
excised lines analyzed and sequenced by PCR amplification.
Transgenic lines were constructed in the P{UAST} vector (Brand and
Perrimon, 1993). P{UAS-dUsp36} contains the CG-5505-RB cDNA subcloned
from LD40339 (Drosophila Genomics Resource Center). P{UAS-dUsp36-IR}318 Cell Host & Microbe 6, 309–320, October 22, 2009 ª2009 Elseviexpresses dUsp36 cDNA sequences cloned in inverted repeats designed
from the Drosophila RNAi Screening Center (http://flyrnai.org) (Flockhart
et al., 2006). P{UAS-Imd-IR} was recovered from the VDRC (#9253) (Dietzl
et al., 2007). Other stocks were recovered from the Drosophila Bloomington
stock center.
HS-driven expression of transgenes was achieved by crossing flies with the
HspGal4 (HSGal4) driver line, and progeny were submitted to sequential
temperature changes: 30 min, 37C; 30 min, 18C; 30 min, 37C; 1 hr, 28C;
16 hr, 25C.
Axenic flies were obtained as described in Brummel et al., 2004.
Northern Blots and Quantitative RT-PCR Analysis
Total RNAs were extracted from adult flies using RNAplus from QBiogene
(Illkirch, France). Northern blots were probed with a 32P-labeled fragment of
dUsp36, Dipt, or Act cDNA. For quantitative RT-PCR analysis, cDNAs were
synthesized with AffinityScript QPCR cDNA Synthesis Kit (Stratagene, Amster-
dam). An amount of cDNA equivalent to 0.01 mg of total RNA was subjected to
40 cycles of PCR amplification consisting of a 10 s incubation at 95C and 30 s
at 60C. Output was monitored using SYBR Green core reagents and the
MX3000P instrument (Stratagene). All the results were normalized to the
RpL32 RNA level. The primer sequences were designed using PrimerQuest
(http://eu.idtdna.com/Scitools/Applications/Primerquest/) and are available
on request.
Construction of a Catalytic Mutant of dUSP36
and In Vitro Deubiquitinating Assays
The cysteine and histidine residues critical for catalysis at positions 111 and
369, respectively, were mutated using QuikChange XL Site-Directed Mutagen-
esis Kit (Stratagene) to obtain dUSP36C111S,H369N (indicated as
dUSP36C*H* throughout the manuscript). In vitro deubiquitinating assays
were performed following standard protocols (see Supplemental Experimental
Procedures).
Immunoprecipitation and Immunoblotting
CoIP was performed in S2-cotransfected cells with 10 mg of Myc-tagged
full-length dUsp36 construct in pAc/HisB vector (Invitrogen; Cergy Pontoise,
France) (dUSP36-Myc) and 10 mg of V5-tagged full-length of IMD, PGRP-LC
(Choe et al., 2005), or KEY (Tsichritzis et al., 2007). Pull-down assays were per-
formed in S2 cells transfected with the IMD-V5 construct and lysed after 48 hr.
The lysate was employed in a GST-dUSP36 N-terminal or C-terminal pull-
down assay. The pull-downs were blotted with antibody against V5 to detect
bound IMD. To assess the enzymatic activity of dUSP36 on ubiquitinated
forms of IMD, we coexpressed 2 mg of pAc-Imd-V5 with 7 mg of empty pAc,
7 mg of pAc-dUsp36-Myc, or pAc-dUsp36C*H*-Myc. To block K48-linked
ubiquitin chain-mediated degradation of proteins by the proteasome,
MG132 was added to cell culture at 20 mM final concentrations for 4 hr. Lysates
were immunoprecipitated with anti-V5 antibody and revealed with either anti-
K63 or anti-K48 antibodies (Newton et al., 2008) provided by Genentech (Saner Inc.
Cell Host & Microbe
Drosophila USP36 Prevents IMD-Dependent SignalsFrancisco). Western blots with whole-cell lysates were revealed with anti-V5 to
detect IMD-V5, anti-Myc to detect dUSP36-Myc or dUSP36C*H*-Myc, or
anti-Tubulin (internal loading control).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six
figures and can be found online at http://www.cell.com/cell-host-microbe/
supplemental/S1931-3128(09)00316-3.
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